article thumbnail

Describing Differences Across Place and Provider in Canadian Team-Based Care Settings Using Electronic Health Records [Health care informatics]

Annals of Family Medicine

In rural areas, TBC can help address challenges arising from limited access to specialized care. In both cases, TBC can help by providing a collaborative approach to care that can better manage the complex needs of patients. The system is used by different provider types to document needs and care in both urban and rural settings.

article thumbnail

From GRP to SIUU – the Evolution of FDA Guidance on Off-Label Dissemination of Scientific Information

FDA Law Blog

By Dara Katcher Levy — Yesterday, FDA published a new Draft Guidance, “ Communications from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers ” (SIUU Guidance or Draft Guidance).

Clinic 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

2009 May;139(1):47-57. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology [published correction appears in J Am Coll Cardiol. J Epidemiol Community Health. 2005;59(5):350-355.

Clinic 52
article thumbnail

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

FDA Law Blog

Part 1 provides background and explains the scope of DEA cyclic and on-site inspections. However, more recently, we have observed that DEA special agents are also becoming more involved in investigations of registrants, thus, raising the stakes for compliance. Background. We will discuss these actions in more detail in later blog.

article thumbnail

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

FDA Law Blog

Part 1 provides background and explains the scope of DEA cyclic and on-site inspections. However, more recently, we have observed that DEA special agents are also becoming more involved in investigations of registrants, thus, raising the stakes for compliance. Background. We will discuss these actions in more detail in later blog.

article thumbnail

SIUU-SIUU-Sudio: FDA Finalizes Guidance on SIUU and Distribution of Off Label Information

FDA Law Blog

And in all seriousness, the finalization of this guidance is somewhat historic given that industry has been relying on various versions of draft Good Reprint Practices guidance since 2009. This final guidance (16 years in the making!) medical or scientific/technical representative or department).

article thumbnail

Is Hospice Losing Its Way: A Podcast with Ira Byock and Joseph Shega

GeriPal

She happened to focus on some specific for-profit hospice providers. They were all actually publicly traded or private equity owned for-profit hospice providers. And I didn’t read it as damning of all for-profit providers, but I think it needed to happen. It feels somewhat random in some ways. Eric: Lack of a caregiver.

IT 114